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ABSTRACT: The JmjC histone lysine demethylases (KDMs)
are epigenetic regulators involved in the removal of methyl
groups from post-translationally modified lysyl residues within
histone tails, modulating gene transcription. These enzymes require
molecular oxygen for catalytic activity and, as 2-oxoglutarate
(2OG)-dependent oxygenases, are related to the cellular oxygen
sensing HIF hydroxylases PHD2 and FIH. Recent studies
have indicated that the activity of some KDMs, including the
pseudogene-encoded KDM4E, may be sensitive to changing
oxygen concentrations. Here, we report detailed analysis of
the effect of oxygen availability on the activity of the KDM4
subfamily member KDM4A, importantly demonstrating a high
level of O2 sensitivity both with isolated protein and in cells.
Kinetic analysis of the recombinant enzyme revealed a high
KM
app(O2) of 173 ± 23 μM, indicating that the activity of the enzyme is able to respond sensitively to a reduction in oxygen
concentration. Furthermore, immunofluorescence experiments in U2OS cells conditionally overexpressing KDM4A showed that
the cellular activity of KDM4A against its primary substrate, H3K9me3, displayed a graded response to depleting oxygen
concentrations in line with the data obtained using isolated protein. These results suggest that KDM4A possesses the potential to
act as an oxygen sensor in the context of chromatin modifications, with possible implications for epigenetic regulation in hypoxic
disease states. Importantly, this correlation between the oxygen sensitivity of the catalytic activity of KDM4A in biochemical and
cellular assays demonstrates the utility of biochemical studies in understanding the factors contributing to the diverse biological
functions and varied activity of the 2OG oxygenases.
■ INTRODUCTION
The organization of genetic material into chromatin enables
not only the compaction of DNA in the nucleus but also
the dynamic regulation of gene transcription. Changes to
chromatin structure affect the accessibility of the DNA to the
transcriptional machinery and are mediated by hundreds of
chromatin-interacting proteins in response to various stimuli.
One such family of chromatin-interacting proteins are the
Jumonji-C-domain-containing histone lysine demethylases
(JmjC-KDMs), which catalyze the removal of methyl groups
from Nε-methylated lysyl residues on histone tails, one of
numerous known post-translational modifications.1 Lysyl
residues at positions 4, 9, 27, 36, and 79 of histone 3 (H3)
may be mono-, di- or tri-Nε-methylated, with methylation at
residues H3K4 and H3K36 generally associated with active
genes and methylation at residues H3K9 and H3K27 with
transcriptional repression. The KDM4 subfamily of enzymes
catalyze demethylation of tri- and dimethylated H3K9
(H3K9me2/3), H3K36me2/3 marks as well as mono- and
dimethylated histone 1.4 lysine 26 (H1.4K26me1/2).2,3
The JmjC-KDMs are members of the Fe2+ and 2-oxoglutarate
(2OG)-dependent oxygenase superfamily, which are characterized
by a conserved double-stranded β helix (DSBH) fold and
share many mechanistic features.4,5 There are over 60 known
human 2OG oxygenases, all of which use molecular oxygen as a
co-substrate in their catalysis of a range of reactions in varied
biological contexts. Some of the more well characterized mem-
bers of this superfamily include the prolyl hydroxylase domain
enzymes 1−3 (PHD1−3) and factor-inhibiting HIF (FIH),
collectively termed the HIF hydroxylases. These enzymes are
responsible for the regulation of hypoxia inducible factor (HIF),
a transcription factor which is considered the master regulator
of the cellular hypoxic response.6 In normoxia, the PHD
enzymes catalyze hydroxylation of HIF at two prolyl residues in
its oxygen-dependent degradation domain, targeting HIF for
proteasomal degradation, while FIH catalyzes hydroxylation of
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an asparaginyl residue in the C-terminal activation domain of
HIF, ablating its interaction with transcriptional coactivators.7
The HIF hydroxylases act as oxygen sensors such that in
moderate hypoxia, their activity is inhibited, allowing HIF to
activate hundreds of target genes8 such as those encoding
for erythropoietin (EPO), glycolytic enzymes, and vascular
endothelial growth factor (VEGF), enabling the cell to adapt to
conditions of low oxygen.7,9,10
There is substantial evidence supporting the proposal that
the 2OG oxygenases act via a consensus mechanism involving
2-electron oxidation of 2OG to form an Fe4+-oxo intermediate,
followed by oxidation of the primary substrate (Figure S1).11
The 2OG oxygenases have a catalytic requirement for molec-
ular oxygen, which has prompted kinetic analyses of this
co-substrate for some members of the superfamily. The
collagen prolyl hydroxylase CP4H and the plant phytanoyl-
CoA hydroxylase mPAHX have relatively low KM
app(O2) values
of 40 and 93 μM, respectively,12,13 suggesting a low degree of
sensitivity to oxygen availability in vitro. In contrast, PHD2
activity is highly sensitive to O2 availability, with reported
KM
app(O2), values ranging between 230 and 1746 μM
12−15 and
a slow reaction with oxygen in pre-steady state kinetic experi-
ments.15 These features, along with the rapid degradation of
HIF, are proposed to underlie its importance as a cellular oxygen
sensor. FIH has a KM
app (O2) of 110 μM,
16 implying a reduced
dependence on oxygen availability and thus a potentially less
significant role in oxygen sensing. Cellular studies have also
demonstrated that PHD2-catalyzed HIF prolyl hydroxylation
is reduced to a greater degree upon reduction of oxygen avail-
ability than HIF asparaginyl hydroxylation catalyzed by FIH.17
Taken together, these results indicate that, although all 2OG
oxygenases use oxygen as a co-substrate, the sensitivity of their
activity with respect to oxygen concentration varies widely across
the superfamily. This raises the question as to whether other
members of the 2OG oxygenase superfamily may also have
an “oxygen-sensing” capacity or whether the HIF hydrox-
ylases, and particularly PHD2, are uniquely sensitive to changes
in oxygen availability.
JmjC-KDM levels and activity have been reported to be
influenced by hypoxia, as has histone methylation status. Our
recent biochemical analysis of KDM4E revealed that its activity
displays a graded response to oxygen over a physiologically
relevant range of oxygen concentrations (0−21%).18 Addition-
ally, a range of KM
app(O2) values for members of the KDM4
subfamily has been reported.19 Some JmjC-KDMs are known
to be HIF target genes and upregulated in hypoxia in various
cell lines (KDM3A, KDM4B, KDM4C, KDM5B, KDM5C, and
KDM6B),20−26 while under hypoxia, KDM3A and KDM4C
have been found to interact or cooperate with HIF at gene
promoters and enhance the induction of HIF target genes in
HCT116 and HeLa cell lines, respectively.27,28 Ectopically
expressed KDM4B demonstrated a loss of cellular demethylase
activity in HeLa cells incubated in hypoxia (0.2% O2), whereas
minimal effects on the activity of KDM3A were observed,
suggesting differential oxygen sensitivity within the HIF-
regulated JmjC-KDMs.21 Furthermore, hypoxia has been
found to induce changes to global (and, in some cases, gene-
specific) histone lysine methylation status in numerous cell
lines, with consequent changes to gene expression pro-
files.23,29−32 While the impact of hypoxia on chromatin
structure is not well-understood, hypoxia in combination
with nutrient depletion was shown to result in chromatin
compaction,33 and the potential role of chromatin as an oxygen
sensor has been postulated.34
These studies on the oxygen-dependence of JmjC-KDMs
and global changes in histone lysine methylation status in
hypoxic cells and tissues suggest that the activity of the JmjC-
KDMs may be differentially modulated by oxygen availability.
This led us to investigate the effect of a range of oxygen con-
centrations on the activity of KDM4A to assess whether this
enzyme has the capacity to function as an oxygen sensor, both
kinetically and in a cellular context. KDM4A was chosen for
investigation as it has been implicated in numerous hypoxic
disease states, including breast, prostate, and lung cancers,35
and cardiac hypertrophy,36 and is a close homologue of KDM4E.
Here, we report that the activity of both recombinant KDM4A
and KDM4A overexpressed in cells displays sensitivity over
physiologically relevant oxygen concentrations. This reveals the
potential for the JmjC-KDMs to play a key role in fine-tuning
transcriptional regulation in an oxygen-dependent manner.
■ RESULTS AND DISCUSSION
Dependence of KDM4A Activity on Oxygen Avail-
ability in Vitro. We initially assessed the sensitivity of isolated
KDM4A demethylase activity at different oxygen concentra-
tions by evaluating the KM
app(O2) of recombinant
KDM4A1−359, which comprises the Jumonji-N and Jumonji-C
domains required for catalytic activity.37 As a prelude, steady-
state kinetic analysis of KDM4A1−359 with respect to 2OG and a
15mer histone peptide substrate H31−15K9me3
38 was first
conducted using a matrix assisted laser desorption / ionization
time-of-flight mass spectrometry (MALDI-TOF-MS) assay.
KM
app values of 24.7 ± 6.7 and 23.2 ± 4.3 μM for 2OG and
H31−15K9me3 peptide substrate, respectively, were determined
(Figure 1a, b) and found to be consistent with reported KM
app
values obtained using other assay methods.38,39 We were then
able to determine excess peptide and 2OG cosubstrate con-
centrations (200 and 100 μM, respectively) for use in the
oxygen dependence assay to ensure saturating conditions of
substrate and cosubstrate.
We then investigated the oxygen dependence of the reaction
of KDM4A1−359 with H31−15K9me3 peptide using a method
described previously.15 Briefly, a mass flow controller (MFC,
Brooks Instruments) was used to regulate the proportion of O2
and N2 used to purge sealed glass vials in which the reaction
was performed. Analysis of the initial rate of reaction at oxygen
concentrations between 0 and 80% (0−722 μM Figure S2)
yielded a KM
app(O2) of 173 ± 23 μM for KDM4A1−359 (Figure 1c).
This value lies between reported KM
app(O2) values of the HIF
hydroxylases FIH and PHD2, as determined using the same
assay (110 and >450 μM, respectively)15,16 and is significantly
higher than reported values for other 2OG oxygenases.12,13,32
This suggests that KDM4A activity may be responsive to
changes in a physiologically relevant range of oxygen concen-
trations, thereby possessing the biochemical potential to act as
an oxygen sensor.
Loss of H3K9me3 in Cells Overexpressing KDM4A is
Dependent on Oxygen Availability. Given that the
differences in the in vitro oxygen sensitivity of the HIF hydrox-
ylases15,16 appeared to correlate with their O2 sensitivities in
cells,17 we next investigated the effect of hypoxia on the cellular
activity of KDM4A to establish whether a similar relationship
between the in vitro and cellular oxygen dependence of the
enzyme was apparent. Furthermore, some previous biochem-
ical studies have reported KM(O2) values that vary with
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peptide length;13 hence, it was important to assess the oxygen
dependence of the enzyme against its endogenous substrate.
HeLa cells were transiently transfected with full-length wild-
type (WT) N-terminally FLAG-tagged KDM4A or the inactive
variant KDM4A H188A2 (MUT) and incubated in either 1 or
21% O2 for 24 h. Cells were stained for immunofluorescence
analysis of FLAG and H3K9me3 levels, with 4′,6-diamidino-2-
phenylindole (DAPI) staining verifying that ectopically expressed
KDM4A was located in the nucleus (Figure 2a−d). Nuclear
FLAG fluorescence signal was used to select a population of
highly transfected cells whose H3K9me3 levels were then quan-
tified (Figure 2e). Similar expression of both WT and MUT
enzymes was observed (Figure 2f). As expected, MUT-transfected
cells displayed no changes in H3K9me3 levels compared to
untransfected cells in either normoxia or hypoxia (Figure 2b,d).
To quantify loss of H3K9me3 in WT-transfected cells, average
H3K9me3 fluorescence signal (RFU) was normalized against
that in MUT-transfected cells incubated at the same oxygen
concentration (Figure S4). In normoxia, the cells overexpressing
WT KDM4A showed a pronounced decrease of 55 ± 11% in
H3K9me3 staining relative to H3K9me3 fluorescence in MUT-
transfected cells, indicating demethylase activity (Figure 2a, b).
In hypoxia, KDM4A WT-transfected cells retained significantly
higher levels of H3K9me3 compared with normoxic cells
(Figure 2a, c) with a percentage loss of 33 ± 11% relative to the
MUT control. This was attributed to an approximately 40%
reduction in KDM4A activity at 1% oxygen relative to that at
21% oxygen (P ≤ 0.05, Figure 2e), suggesting that cellular
KDM4A catalytic activity is sensitive to reduction in oxygen
availability.
Cellular KDM4A Activity Demonstrates a Graded
Response to Hypoxia. We next assessed the cellular KDM4A
demethylase activity across a range of physiologically relevant
oxygen concentrations to ascertain its sensitivity to cellular oxy-
gen availability. To facilitate this and to test whether KDM4A
activity can also be modulated by hypoxia in a different cell
line, a U2OS cell line stably expressing doxycycline-inducible
FLAG-tagged WT KDM4A (full length) (herein termed U2OS
F-KDM4A cells) was used (Figure S3).
Doxycycline hyclate was added to U2OS F-KDM4A cells,
which were subsequently incubated at 0.1, 1, 5 and 21% O2,
for 24 h. Cells were then fixed and stained for FLAG and
H3K9me3 (Figure 3a−d). At each oxygen concentration, global
H3K9me3 levels were normalized to those in uninduced U2OS
F-KDM4A cells incubated under the same conditions to
account for endogenous responses of the mark to hypoxia. Loss
of H3K9me3 fluorescence in induced cells was then used to
calculate percentage demethylation of this mark by the over-
expressed KDM4A and correlated with KDM4A activity
(Figure 3e; for calculations, see Figure S4). The percentage
loss of H3K9me3 in KDM4A induced U2OS cells at 1% O2 was
relatively consistent with loss of H3K9me3 found in HeLa cells
transiently transfected with KDM4A (50 ± 5% compared with
∼40%, respectively), indicating a similar effect of hypoxia on
KDM4A activity in different cell lines. Overall, the data revealed
a relative decrease in the demethylation of H3K9me3 con-
sistent with a graded loss of KDM4A activity with decreasing
oxygen concentration. As expected, HIF-1α stabilization was
also observed for cells incubated at reduced oxygen concen-
trations (0.1−5.0% O2) by Western blot analysis (Figure 3f(i)).
Interestingly, we also observed an increase in KDM4A at the
protein level with decreasing oxygen concentration in U2OS
F-KDM4A cells (Figure 3f(ii),g) independent of changes at the
transcript level (Figure 3h), suggesting that our analysis from
immunofluorescence experiments may be underestimating the
effect of hypoxia on loss of KDM4A activity because of increased
FLAG-KDM4A expression. This increase in KDM4A protein is
consistent with a recent study by Black et al, who observed a
reduction of KDM4A activity against H3K9me3 in RPE cells
exposed to 1% O2 for 24 h.
40 However, although chemical
inhibition of JmjC-KDM activity abrogated KDM4A-mediated
transient site-specific copy gain in hypoxia, hypoxic loss of
activity did not have the same effect,40 suggesting that the
downstream physiological effects of hypoxia on KDM4A func-
tion are somewhat subtle. Previous studies have revealed that
stabilization of KDM4A in hypoxia is due to reduced interaction
Figure 1. Kinetic analysis of recombinant KDM4A1−359 using a
MALDI-TOF-MS-based assay. KM
app values for (a) 2OG and
(b) H31−15K9me3 for KDM4A1−359 were initially determined.
(c) Steady-state determination of KDM4A1−359 kinetics with respect
to oxygen revealed a KM
app(O2) of 173 ± 23 μM. An approximately
5−10 fold excess of KMapp 2OG and H31‑15K9me3 peptide was used to
ensure saturating conditions of all (co)substrates at 37 °C. GraphPad
Prism was used to fit data to a Michaelis-Menten model and evaluate
kinetic parameters. A total of three biological repeats using different
preparations of KDM4A1−359 with n = 3 technical repeats were
performed; error bars denote standard deviation (sd).
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of the enzyme with the SKP1-Cul1-F-box ubiquitin ligase
responsible for regulation of KDM4A turnover by the pro-
teasome.41 Given the reduced catalytic activity of KDM4A in
hypoxia, this stabilization may be a compensatory mechanism,
as has been suggested regarding the HIF-induced upregulation
of KDM4 isoforms KDM4B and KDM4C.21,22 Indeed, hypoxic
stabilization of KDM4A has been shown to increase its asso-
ciation with chromatin,41 thereby potentially ameliorating the
effects of hypoxia on its catalytic activity and rationalizing the
different effects observed upon chemical and hypoxic inhibition
of KDM4A.40 Although the biological implications of the
observed oxygen sensitivity are yet to be elucidated, our exper-
iments in U2OS F-KDM4A cells suggest that both KDM4A
activity and protein levels can be “tuned” in varying degrees of
hypoxia, which may be further indication of an oxygen sensing
role for KDM4A.
Quantitative Western blots were performed to assess the
effect of hypoxia on KDM4A activity against multiple meth-
ylated lysine marks (H3K9me3, H3K36me3, H3K27me3,
and H3K4me3) in total populations of both induced and
uninduced U2OS F-KDM4A cells as well as a control parental
U2OS cell line (U2OS (P), Figure S3). Multiplexed fluo-
rescent analysis allowed levels of these methylation marks to
be normalized against a simultaneously quantified H3 loading
control for each sample (Figure 4a). Normalized values from
induced samples were then compared to those in uninduced
samples incubated at the same concentration of O2, and the
relative loss of methylation due to overexpression of KDM4A in
each condition was calculated. The Western blots confirmed
that induction of KDM4A overexpression led to a significant
decrease in H3K9me3 levels in normoxia (Figure 4b(i)).
Moderate and graded reduction in H3K9me3 levels and, to a
lesser extent, H3K36me3 levels was observed in KDM4A
overexpressing cells in hypoxia (Figure 4b(ii)), displaying a
similar trend to that seen in immunofluorescence experiments.
Although levels of the non-KDM4A-substrate H3K4me3 mark
demonstrated no significant changes on overexpression of
KDM4A (Figure 4b(iv)), interestingly, analysis of the H3K27me3
mark showed loss of this mark upon overexpression of KDM4A
in normoxia, with a graded response to oxygen (Figure 4b(iii))
similar to that seen for H3K9me3, although less-pronounced.
H3K27me3 is not a canonical substrate for KDM4A, hence,
loss of this mark cannot be directly attributed to catalytic
KDM4A activity. However, KDM4A has been shown to be
capable of catalyzing demethylation of a H3K27me3 peptide
substrate in vitro.42 It is also possible that global demethyla-
tion of H3K9me3 and H3K36me3 affects the H3K27me3
mark through alternative pathways. There is increasing evi-
dence to suggest that the function, selectivity, and activity of
individual JmjC-KDMs is affected by the presence or absence of
Figure 2. Hypoxia-dependent alteration of H3K9me3 levels in HeLa cells overexpressing FLAG-KDM4A. (a−d) Selected images from immuno-
fluorescence analysis of the effect of hypoxia on the cellular activity of KDM4A. HeLa cells were transiently transfected with FLAG-tagged full length
KDM4A WT (a,c) or catalytically inactive KDM4A MUT (b,d) and then incubated for 24 h at 21% (a,b) or 1% O2 (c,d). Images were processed and
analyzed at the same time using the same fluorescence intensity signal window. (e) Calculation of relative loss of H3K9me3 in normoxia (21% O2)
and hypoxia (1.0% O2) reveals an approximately 40% reduction in hypoxia. Error bars denote sd; N = 3; a paired t test was performed using
GraphPad Prism; P ≤ 0.05. For the calculation method, see Figure S4. (f) Expression of transiently expressed FLAG-tagged KDM4A WT and
KDM4A MUT is comparable in normoxia and hypoxia. Average FLAG fluorescence signal in KDM4A MUT-overexpressing cells was normalized
against that in KDM4A WT-overexpressing cells in the cell populations selected for analysis (n > 50 cells). No significant differences in FLAG signal
were apparent. Error bars denote sd; N = 3; two-way ANOVA was performed using GraphPad Prism; P ≤ 0.05.
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post-translational modifications distal to the mark upon which
they are acting via disruption of necessary interactions with
binding and reader domains;43,44 hence, aberrant demethylation
of one lysine methylation mark may have an impact on others.
Aberrant histone lysine methylation and altered JmjC-KDM
expression levels have been observed in hypoxic disease states
such as cancer35 and cardiovascular diseases such as
cardiomyopathy and cardiac hypertrophy.32,36,45 The potential
Figure 3. Cellular demethylase activity of KDM4A demonstrates a graded response to oxygen concentration in U2OS cells. (a−d). Representative
images from immunofluorescence analysis of the oxygen sensitivity of cellular KDM4A. Doxycycline (Dox)-inducible U2OS stable cells were induced
to overexpress FLAG-KDM4A WT and incubated at (a) 0.1%, (b) 1.0%, (c) 5.0%, or (d) 21% O2 for 24 h. H3K9me3 signal in induced cells
(indicated by arrows) was normalized against signal in uninduced cells and correlated to enzyme activity (Figure S4). (e) Cellular KDM4A H3K9me3
demethylase activity in O2 concentrations from 0.1 to 5.0% relative to 21%. Quantification is based on three biological repeats; error bars denote sd.
One-way ANOVA with Dunnett’s multiple comparison test against the result for 21% O2 was performed in GraphPad Prism. N > 50 cells were used
for each experiment; cells incubated in each oxygen concentration were processed, imaged, and analyzed simultaneously. (f)(i)Western blot analysis
of cell lysates from induced and uninduced U2OS F-KDM4A and parental U2OS cells (P) reveals stabilization of HIF-1α in cells incubated at 0.1−
5.0% O2 compared to cells incubated at 21% O2. β-actin was used as a loading control. (ii) Multiplexed fluorescent Western blot (red, anti-KDM4A;
green, anti- FLAG and anti-actin) and (g) quantitative graph showing levels of FLAG-KDM4A protein in U2OS F-KDM4A cells treated ± dox and
incubated at 0.1−21% O2 for 24 h. The membrane was stained simultaneously for KDM4A, FLAG, and β-actin to enable direct quantification and
comparison. P denotes parental U2OS cells, which were used to control for dox-dependent effects. All signals were normalized to the β-actin loading
control. Levels of overexpressed FLAG-KDM4A were quantified relative to those in normoxic cells treated with dox. Quantitation is based on three
biological repeats; error bars denote sd and two-way ANOVA with Dunnett’s multiple comparison test was performed using GraphPad Prism. (h)
Hypoxia does not affect expression levels of KDM4A mRNA. Relative mRNA levels of KDM4A U2OS F-KDM4A cells ± dox incubated for 24 h in
0.1% −21% oxygen, and U2OS parental cells (P) incubated at 1.0 and 21% O2, were analyzed by RT-qPCR. A two-way ANOVA with Dunnett’s
multiple comparison was performed using GraphPad Prism; error bars denote sd; N = 2; control= −dox; and 21% O2.
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involvement of the JmjC-KDMs in these hypoxic diseases
highlights the importance of understanding the impact of
hypoxia on their activity. Here, we demonstrate a link between
the biochemical oxygen sensitivity of isolated KDM4A and the
effect of cellular hypoxia on its catalytic activity, with a loss
of KDM4A activity in hypoxia resulting in changes to global
histone lysine methylation. A comparative study with which to
assess the oxygen sensitivity of multiple demethylases using the
Figure 4. Alteration of multiple H3 methylation marks by KDM4A at different oxygen concentrations. (a) Fluorescent Western blots showing levels
of H3K9me3, H3K36me3, and H3K27me3 histone methylation marks in induced or uninduced U2OS F-KDM4A cells incubated at 0.1−21% O2.
P denotes parental U2OS cells. The membrane was stained simultaneously for H3K9me3, H3K36me3, H3K27me3, H3K4me3, and H3, with
methylation marks being normalized against the signal for H3. Representative Western blots are shown and have been cropped to show only relevant
molecular weights. Western blots were imaged using Odyssey CLx fluorescent imaging system (LI-COR) and analyzed using Image Studio software
(LI-COR). (b) Graphs showing quantification of (i) H3K9me3, (ii) H3K36me3, (iii) H3K27me3, and (iv) H3K4me3 levels from Western blots.
Levels of trimethylated lysine marks were normalized to H3 levels and then quantitated relative to those in uninduced cells incubated at the same O2
concentration to discount any non-KDM4A mediated effect in methylation changes. Error bars denote sd and one-way ANOVA with Dunnett’s
multiple comparison test was performed using GraphPad Prism; N = 3.
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methods described herein would further develop our under-
standing of the potential for differential oxygen sensitivity
across the JmjC-KDMs, as has previously been observed both
in cells21,46 and in vitro, particularly for the KDM4 subfamily.19
Overall, however, these results suggest that KDM4A pos-
sesses the potential to act as an oxygen sensor in the context of
epigenetic regulation. While these observations are yet to be
validated in an endogenous setting, importantly, they present a
possible complementary mechanism to the HIF pathway for
hypoxic regulation of gene expression.
■ METHODS
Recombinant KDM4A Assays. N-terminally His6-tagged trun-
cated KDM4A1−359 was expressed in Escherichia coli BL21(DE3) cells
and purified via nickel affinity followed by size-exclusion chromatog-
raphy, as reported previously.37 H31−15K9me3 peptide was synthesized
using a Liberty Blue automated microwave peptide synthesizer (CEM)
and purified via reverse-phase high-performance liquid chromatog-
raphy (HPLC). Activity assays were performed using the following
conditions: 1 μM KDM4A1−359, 200 μM H31−15K9me3, 200 μM 2OG,
100 μM L-ascorbate, and 10 μM Fe2+ in 50 mM HEPES (pH 7.5).
Experiments to determine KM values of H31−15K9me3, 2OG, and
O2 used these conditions but varied the concentration of the (co)sub-
strate under investigation. For oxygen-dependence assays, the activity
of KDM4A1−359 was assessed at varied oxygen concentrations. Peptide
and buffer (94 μL) were equilibrated in septa-sealed glass vials for
5 min at 37 °C using a mass flow controller (Brooks Instruments) to
control the ratios of O2 to N2. Sequential addition of 2OG (1 μL),
L-ascorbate (1 μL), and Fe2+ (2 μL) was followed by initiation of the
enzymatic reaction by addition of KDM4A1−359 (1 μL) using gastight
Hamilton syringes and incubation at 37 °C for 5 min. The reaction
was quenched with MeOH in a 1:1 ratio and 1 μL removed for
analysis via MALDI-TOF-MS.
Stable Transfectants. The human KDM4A gene was cloned into
a modified pUHD10-3 MCS vector to enable expression of an
N-terminally FLAG-tagged KDM4A protein. Stable transfectants were
then generated from U2OS cells bearing the reverse tetracycline
responsive transactivator47 and a tetKRAB silencer construct48 by
transfection with the pUHD10 FLAG vector alone or pUHD10-FLAG-
KDM4A in combination with pSV2-hph (ratio 10:1) using FuGENE
6 (Roche Applied Science). A total of 24 h after transfection, cells were
selected with hygromycin B (150 μgml−1). Independent clones were
picked, maintained in selection media (Dulbecco’s modified Eagle’s
medium supplemented with 10% Tet system-approved fetal bovine
serum (FBS, Clontech), penicillin G (50 IU mL−1), streptomycin
(50 μg mL−1) (Invitrogen), L-glutamine (2 mM) (Sigma), blasticidin S
(5 μg mL−1) (Invitrogen), and hygromycin B (150 μg mL−1; Roche
Applied Science)) and tested for doxycycline-inducible gene expression
(Figure S2). Clone 1 was verified and used for experiments (Figure S3).
HeLa Cells. HeLa cells were maintained in DMEM media
supplemented with 10% FBS and 5% L-glutamine and incubated at
37 °C, 5% CO2, and the required O2 concentration. Cells were trans-
fected with pCDNA3 encoding full length, N-terminally FLAG-tagged
KDM4A or KDM4A H188A variant using FuGENE HD transfection
reagent (Promega) according to the manufacturer’s protocol. For
immunofluorescence experiments, after 4 h, the media on the cells was
changed and the cells transferred to the relevant experimental conditions.
U2OS FLAG-KDM4A Cells. U2OS FLAG-KDM4A cells were
maintained in selection media throughout experiments and incubated
at 37 °C, 5% CO2 and the required O2 concentration. Cells were
dosed with doxycycline (1 μg mL−1) or left untreated and then trans-
ferred immediately to relevant experimental conditions.
Hypoxic Cellular Experiments. Hypoxic incubations of cells were
performed in an Invivo2 400 hypoxic workstation (Ruskinn
Technologies). All O2 gradient assays were performed simultaneously
in hypoxic chambers set at 0.1, 1.0 and 5.0% O2, with normoxic cells
maintained at 21% O2. For immunofluorescence experiments and
Western blots of histone marks, cells were removed from the hypoxic
stations prior to fixing or scraping, respectively. For HIF Western
blots, cells were scraped in the hypoxic workstations.
Immunofluorescence. A protocol adapted from King et al, 201049
was used for immunofluorescence assays. Briefly, after 24 h of incubation
at the required oxygen concentration, cells were fixed, permeabilized and
stained for FLAG and H3K9me3 (see Table S1 for a list of antibodies)
and DAPI (Sigma D9564) to stain DNA. Goat anti-rabbit secondary
antibody conjugated to Alexa Fluor 488 (Life Technologies A11034) and
goat anti-mouse secondary antibody conjugated to Alexa Fluor 594 (Life
Technologies A11032) were used to fluorescently label the FLAG and
H3K9me3 primary antibodies. All fixing and staining procedures were
performed simultaneously for each biological experiment. Image
acquisition was performed using an Operetta high content imaging
system (PerkinElmer), and images were analyzed using Harmony high
content imaging and analysis software (PerkinElmer). Cell nuclei were
automatically identified by DAPI staining using the default parameters.
Cells overexpressing high amounts of KDM4A, where FLAG-tag staining
was bright, were selected for analysis of H3K9me3 levels. In HeLa cells,
H3K9me3 levels were normalized against those in cells transfected with
the catalytically inactive KDM4A variant, which was deemed to possess
0% activity, while in U2OS FLAG-KDM4A cells, uninduced cells were
used for normalization.
Western Blots. Following hypoxic or normoxic incubation, cells
were scraped on ice in SDS−urea buffer (6.7 M urea, 10 mM Tris−Cl
(pH 6.8), 10% v/v glycerol, and 1% w/v SDS supplemented with 1
mM dithiothreitol and Complete Protease Inhibitor mixture (Roche
Applied Science)). Lysates were then sonicated on ice for 10 s three
times with a 10 s pause between cycles and snap-frozen at −80 °C.
Total protein concentration was determined using a Pierce BCA assay
kit (Thermo Scientific). Protein (1 μg total per well) was loaded on a
NuPage 4−12% Bis−Tris gel (Life Technologies) and then transferred
to a 0.45 μm nitrocellulose membrane using wet transfer at 30 V for
1 h. Membranes were blocked in SEA BLOCK blocking buffer
(Thermo Scientific) overnight then probed with primary and fluo-
rescent secondary antibodies (see Table S1) diluted in 3% SEA-
BLOCK, PBS, and 0.1% Tween-20. Blots were imaged on an Odyssey
CLx Fluorescent Imaging System (LI-COR) and analyzed using Image
Studio software (LI-COR).
qPCR. RNA was isolated and purified from cells using the mirVana
miRNA isolation kit (Life Technologies) according to the manu-
facturer’s protocol. Isolated RNA was then treated with DNase using a
Turbo DNA-free kit (Invitrogen) to remove DNA before reverse
transcription using a High-Capacity cDNA Reverse Transcription kit
(Applied Biosystems). A total of 1.5625 ng of cDNA was submitted to
qPCR analysis using 300 nM primers (Sigma; see Table S2 for primer
sequences) and Power SYBR Green Master Mix (Applied Biosystems)
according to the manufacturer’s protocol in a CFX1000 Thermal
Cycler with a CFX96 Real-Time System (Bio-Rad). Data was collected
and processed using CFX Manager Software v3.1 (Bio-Rad) and
analyzed using the ΔCt method.
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